ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00622622
Recruitment Status : Completed
First Posted : February 25, 2008
Last Update Posted : February 18, 2009
Sponsor:
Collaborator:
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Wakayama Medical University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2006
  Actual Study Completion Date : February 2009
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):